Unknown

Dataset Information

0

O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit.


ABSTRACT: Advanced colorectal cancer (CRC) is one of the deadliest cancers, and the 5-year survival rate of patients with metastasis is extremely low. The epithelial-mesenchymal transition (EMT) is considered essential for metastatic CRC, but the fundamental molecular basis underlying this effect remains unknown. Here, we identified that O-GlcNAcylation, a unique posttranslational modification (PTM) involved in cancer metabolic reprogramming, increased the metastatic capability of CRC. The levels of O-GlcNAcylation were increased in the metastatic CRC tissues and cell lines, which likely promoted the EMT by enhancing EZH2 protein stability and function. The CRC patients with higher levels of O-GlcNAcylation exhibited greater lymph node metastasis potential and lower overall survival. Bioinformatic analysis and luciferase reporter assays revealed that both O-GlcNAcylation transferase (OGT) and EZH2 are posttranscriptionally inhibited by microRNA-101. In addition, O-GlcNAcylation and H3K27me3 modification in the miR-101 promoter region further inhibited the transcription of miR-101, resulting in the upregulation of OGT and EZH2 in metastatic CRC, thus forming a vicious cycle. In this study, we demonstrated that O-GlcNAcylation, which is negatively regulated by microRNA-101, likely promotes CRC metastasis by enhancing EZH2 protein stability and function. Reducing O-GlcNAcylation may be a potential therapeutic strategy for metastatic CRC.

SUBMITTER: Jiang M 

PROVIDER: S-EPMC6336687 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit.

Jiang Mingzuo M   Xu Bing B   Li Xiaowei X   Shang Yulong Y   Chu Yi Y   Wang Weijie W   Chen Di D   Wu Nan N   Hu Sijun S   Zhang Song S   Li Mengbin M   Wu Kaichun K   Yang Xiaoyong X   Liang Jie J   Nie Yongzhan Y   Fan Daiming D  

Oncogene 20180809 3


Advanced colorectal cancer (CRC) is one of the deadliest cancers, and the 5-year survival rate of patients with metastasis is extremely low. The epithelial-mesenchymal transition (EMT) is considered essential for metastatic CRC, but the fundamental molecular basis underlying this effect remains unknown. Here, we identified that O-GlcNAcylation, a unique posttranslational modification (PTM) involved in cancer metabolic reprogramming, increased the metastatic capability of CRC. The levels of O-Glc  ...[more]

Similar Datasets

| S-EPMC5074303 | biostudies-literature
| S-EPMC8282501 | biostudies-literature
| S-EPMC6326693 | biostudies-other
| S-EPMC4466650 | biostudies-literature
| S-EPMC8282380 | biostudies-literature
| S-EPMC7848292 | biostudies-literature
| S-EPMC7205996 | biostudies-literature
| S-EPMC4231742 | biostudies-literature
| S-EPMC8633590 | biostudies-literature
| S-EPMC8570098 | biostudies-literature